Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue

Blood blood.2024025127.

https://doi.org/10.1182/blood.2024025127

Published: 2024

Includes: Supplemental data

Journal Articles

The Effect of Immunoglobulin Prophylaxis on Infectious Morbidity in Pediatric Patients with Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial

Kirsten Thus, Hester A. de Groot-Kruseman, Pauline Winkler-Seinstra, Heidi Segers, Cor van den Bos, Inge M. Van Der Sluis, Wim Tissing, Margreet A. Veening, Michel C. Zwaan, Marta F. Fiocco, Cornelis van Tilburg, Rob Pieters, Marc Bierings

Blood (2023) 142 (Supplement 1): 2839.

https://doi.org/10.1182/blood-2023-173418

Published: 2023

Journal Articles

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Blood (2023) 142 (18): 1570–1575.

https://doi.org/10.1182/blood.2023021212

Published: 2023

Includes: Supplemental data

Journal Articles

Implementation of Continuous Pegasparaginase Dosing without an Asparaginase-Free Interval Reduces Hypersensitivity in Children with Newly Diagnosed Acute Lymphoblastic Leukemia: Results of the DCOG ALL11 Pegasparaginase Randomization

Leiah J. Brigitha, Rob Pieters, Marta F. Fiocco, Hester A. de Groot-Kruseman, Marc Bierings, Cor Van Den Bos, Valerie de Haas, Peter M. Hoogerbrugge, Wim J.E. Tissing, Margreet A. Veening, Inge M. Van Der Sluis

Blood (2023) 142 (Supplement 1): 2883.

https://doi.org/10.1182/blood-2023-173359

Published: 2023

Journal Articles

Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients

Blood (2023) 142 (13): 1167–1171.

https://doi.org/10.1182/blood.2023020569

Published: 2023

Includes: Supplemental data

Journal Articles

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M. van Noesel, Jan A. M. van Laar, Robert M. Verdijk, Uta E. Flucke, Pancras C. W. Hogendoorn, F. J. Sherida H. Woei-A-Jin, Raf Sciot, Andreas Beilken, Friedrich Feuerhake, Martin Ebinger, Robert Möhle, Falko Fend, Antje Bornemann, Verena Wiegering, Karen Ernestus, Tina Méry, Olga Gryniewicz-Kwiatkowska, Bozenna Dembowska-Baginska, Dmitry A. Evseev, Vsevolod Potapenko, Vadim V. Baykov, Stefania Gaspari, Sabrina Rossi, Marco Gessi, Gianpiero Tamburrini, Sébastien Héritier, Jean Donadieu, Jacinthe Bonneau-Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Marie-Laure Jullié, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale M. Barbaro, Alysa Poulin, Ingrid S. Tam, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna L. Weinstein, Irem Eldem, Bryan A. Sisk, Vaishnavi Sridhar, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova-Drus, Stephen Z. Peeke, Laura S. Muñoz-Arcos, Daniel G. Leino, David D. Grier, Robert Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, Michael M. Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean-François Emile

Blood (2022) 139 (2): 256–280.

https://doi.org/10.1182/blood.2021013338

Published: 2022

Includes: Supplemental data

Journal Articles

Bone marrow–derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis

Yanling Xiao, Astrid G. S. van Halteren, Xin Lei, Jelske Borst, Eline Steenwijk, Tom de Wit, Joanna Grabowska, Rhianne Voogd, Paul Kemps, Jennifer Picarsic, Cor van den Bos, Jannie Borst

Blood (2020) 136 (19): 2188–2199.

https://doi.org/10.1182/blood.2020005209

Published: 2020

Includes: Supplemental data

Journal Articles

Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients Receiving Vincristine through Push Injections or One-Hour Infusions: Results of a Randomized Clinical Trial

Mirjam Esther Van De Velde, MD, Gertjan Johannes Laurentius Kaspers, Prof. MD PhD, Floor Abbink, MD, Marry M. van den Heuvel-Eibrink, Prof, MD PhD, Cor van den Bos, MD PhD, Inge M. van der Sluis, MD PhD, Heidi Segers, MD PhD, Leen Willems, MD PhD, Jutte Van Der Werff, Prof, MD PhD, Christophe Chantrain, MD PhD, Machteld Heleen van den Berg, PhD

Blood (2019) 134 (Supplement_1): 1350.

https://doi.org/10.1182/blood-2019-126532

Published: 2019

Journal Articles

Vincristine Induced Peripheral Neuropathy: A Randomized Controlled Trial Comparing Bolus Injections with One Hour Infusions during Induction in a Pediatric Population of Acute Lymphoblastic Leukemia and Hodgkin's Lymphoma

Mirjam Esther Velde, MD MSc, Machteld Heleen van den Berg, PhD, Floor Abbink, MD, Heidi Segers, MD PhD, Barbara De Moerloose, MD PhD, Marry M. van den Heuvel-Eibrink, Prof, Cor van den Bos, MD PhD, Inge M. van der Sluis, MD PhD, Gertjan Johannes Laurentius Kaspers, MD PhD

Blood (2018) 132 (Supplement 1): 5200.

https://doi.org/10.1182/blood-2018-99-115905

Published: 2018

Journal Articles

Hemophagocytic Lymphohistiocytosis (HLH) in Langerhans Cell Histiocytosis (LCH): A Multicenter Retrospective Descriptional Study

Deepak Chellapandian, MD MBBS, Rui Zhang, MD, Michael Jeng, MD, Cor Van Den Bos, MD PhD, Vicente Santa-María López, MD, Kai Lehmberg, MD, Elena Sieni, MD, Yini Wang, MD, Taizo Allen Nakano, MD, James Williams, MD, Nicholas J. Fustino, MD, Itziar Astigarraga, MD, Ira Dunkel, MD, Qi An, Cheng Cheng, PhD, Sheila Weitzman, MB BCh, FRCP, Lillian Sung, MD PhD, Kim E. Nichols, MD

Blood (2016) 128 (22): 707.

https://doi.org/10.1182/blood.V128.22.707.707

Published: 2016

Journal Articles

Population Pharmacokinetics of Erwinia Asparaginase in Pediatric ALL Patients

Sebastiaan D.T. Sassen, PharmD, Ron A.A. Mathôt, PharmD, PhD, Rob Pieters, MD PhD, Valerie de Haas, MD PhD, Gertjan JL Kaspers, MD PhD, Cor van den Bos, MDPhD, Wim JE Tissing, MD PhD, Maroeska D.W.M. te Loo, MD PhD, Marc B Bierings, MDPhD, Wouter J.W. Kollen, MD PhD, Christian M. Zwaan, MD PhD, Inge M. van der Sluis, MD PhD

Blood (2015) 126 (23): 1281.

https://doi.org/10.1182/blood.V126.23.1281.1281

Published: 2015

Journal Articles

A Double Blind Randomised Clinical Trial to Prevent Serious Side Effects of Dexamethasone during Pediatric Acute Lymphoblastic Leukemia Treatment

Lidewij T Warris, MD, Marry M van den Heuvel-Eibrink, MD PhD, Femke K Aarsen, MSc PhD, Saskia MF Pluijm, Marc B Bierings, MDPhD, Cor van den Bos, MDPhD, Christian M. Zwaan, MD PhD, Wim JE Tissing, MD PhD, Margreet A Veening, MD, Rob Pieters, MD PhD, Erica LT van den Akker, MDPhD

Blood (2015) 126 (23): 2495.

https://doi.org/10.1182/blood.V126.23.2495.2495

Published: 2015

Journal Articles

Bisphosphonate Therapy in Langerhans Cell Histiocytosis: An International Retrospective Descriptive Study

Deepak Chellapandian, MD MBBS, Polyzois Makras, MD PhD, Gregory Kaltsas, MD PhD, Cor van den Bos, MDPhD, Anne-Sophie Carret, MD, Sheila Weitzman, MB BCh, FRCP, Maarten Egeler, MD PhD, Oussama Abla, MD

Blood (2015) 126 (23): 2209.

https://doi.org/10.1182/blood.V126.23.2209.2209

Published: 2015

Journal Articles

Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study

Jean Donadieu, Frederic Bernard, Max van Noesel, Mohamed Barkaoui, Odile Bardet, Rosella Mura, Maurizio Arico, Christophe Piguet, Virginie Gandemer, Corinne Armari Alla, Niels Clausen, Eric Jeziorski, Anne Lambilliote, Sheila Weitzman, Jan Inge Henter, Cor Van Den Bos, the Salvage Group of the Histiocyte Society

Blood (2015) 126 (12): 1415–1423.

https://doi.org/10.1182/blood-2015-03-635151

Published: 2015

Includes: Supplemental data

Journal Articles

Somatic activating ARAF mutations in Langerhans cell histiocytosis

David S. Nelson, Willemijn Quispel, Gayane Badalian-Very, Astrid G. S. van Halteren, Cor van den Bos, Judith V. M. G. Bovée, Sara Y. Tian, Paul Van Hummelen, Matthew Ducar, Laura E. MacConaill, R. Maarten Egeler, Barrett J. Rollins

Blood (2014) 123 (20): 3152–3155.

https://doi.org/10.1182/blood-2013-06-511139

Published: 2014

Includes: Supplemental data

Journal Articles

A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia

Wing H. Tong, Rob Pieters, Gertjan J. L. Kaspers, D. Maroeska W. M. te Loo, Marc B. Bierings, Cor van den Bos, Wouter J. W. Kollen, Wim C. J. Hop, Claudia Lanvers-Kaminsky, Mary V. Relling, Wim J. E. Tissing, Inge M. van der Sluis

Blood (2014) 123 (13): 2026–2033.

https://doi.org/10.1182/blood-2013-10-534347

Published: 2014

Includes: Supplemental data

Journal Articles

A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia

Wing H. Tong, MD, Rob Pieters, Gertjan Kaspers, MD, PhD, Maroeska D.W.M. te Loo, MD, PhD, Marc Bierings, Cor van den Bos, MD, PhD, Wouter J.W. Kollen, MD, PhD, Wim C.J. Hop, PhD, Joachim Boos, MD, PhD, Mary V. Relling, PharmD, Hans Juergen Kuehnel, MD, Wim J Tissing, MD, PhD, Inge M. van der Sluis, MD, PhD

Blood (2013) 122 (21): 2634.

https://doi.org/10.1182/blood.V122.21.2634.2634

Published: 2013

Journal Articles

Risk Of Solid Subsequent Malignant Neoplasms (SMNs) With Extended Follow-Up Of Childhood Hodgkin Lymphoma (HL) Survivors Is Comparable To The Risk In Known High-Risk Groups Within The General Population: Report From The Late Effects Study Group (LESG)

Smita Bhatia, MD, MPH, Cor van den Bos, MD, PhD, Can-Lan Sun, PhD, Jillian Birch, MD, Lisa Diller, MD, Kimberley Dilley, MD, MPH, FAAP, Jill Ginsberg, Laura Therese Martin, MD, Rajaram Nagarajan, MD, MS, Joseph P. Neglia, MD, MPH, Monica Terenziani, MD, David Tishler, MD, Anna T Meadows, MD, Leslie L. Robison, PhD, MPH, Odile Oberlin, MD, Jennifer P. Berano Teh, MD

Blood (2013) 122 (21): 2992.

https://doi.org/10.1182/blood.V122.21.2992.2992

Published: 2013

Journal Articles

The Effect of Fresh Frozen Plasma On the Incidence of Venous Thromboembolism and Haemorrhages in Children with Acute Lymphoblastic Leukaemia

Charlotte CM Zuurbier, Eva Stokhuijzen, Cor van den Bos, Antoinette YN Schouten-van Meeteren, C Heleen Van Ommen

Blood (2012) 120 (21): 1471.

https://doi.org/10.1182/blood.V120.21.1471.1471

Published: 2012

Journal Articles

Transplantation of Human Umbilical Cord Blood Cells in Macrophage-Depleted SCID Mice: Evidence for Accessory Cell Involvement in Expansion of Immature CD34 + CD38 − Cells

Monique M.A. Verstegen, Paula B. van Hennik, Wim Terpstra, Cor van den Bos, Jenne J. Wielenga, Nico van Rooijen, Rob E. Ploemacher, Gerard Wagemaker, Albertus W. Wognum

Blood (1998) 91 (6): 1966–1976.

https://doi.org/10.1182/blood.V91.6.1966

Published: 1998

NARROW

Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue

The Effect of Immunoglobulin Prophylaxis on Infectious Morbidity in Pediatric Patients with Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Implementation of Continuous Pegasparaginase Dosing without an Asparaginase-Free Interval Reduces Hypersensitivity in Children with Newly Diagnosed Acute Lymphoblastic Leukemia: Results of the DCOG ALL11 Pegasparaginase Randomization

Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Bone marrow–derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis

Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients Receiving Vincristine through Push Injections or One-Hour Infusions: Results of a Randomized Clinical Trial

Vincristine Induced Peripheral Neuropathy: A Randomized Controlled Trial Comparing Bolus Injections with One Hour Infusions during Induction in a Pediatric Population of Acute Lymphoblastic Leukemia and Hodgkin's Lymphoma

Hemophagocytic Lymphohistiocytosis (HLH) in Langerhans Cell Histiocytosis (LCH): A Multicenter Retrospective Descriptional Study

Population Pharmacokinetics of Erwinia Asparaginase in Pediatric ALL Patients

A Double Blind Randomised Clinical Trial to Prevent Serious Side Effects of Dexamethasone during Pediatric Acute Lymphoblastic Leukemia Treatment

Bisphosphonate Therapy in Langerhans Cell Histiocytosis: An International Retrospective Descriptive Study

Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study

Somatic activating ARAF mutations in Langerhans cell histiocytosis

A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia

A Prospective Study On Drug Monitoring Of Pegasparaginase and Erwinia Asparaginase and Asparaginase Antibodies In Pediatric Acute Lymphoblastic Leukemia

Risk Of Solid Subsequent Malignant Neoplasms (SMNs) With Extended Follow-Up Of Childhood Hodgkin Lymphoma (HL) Survivors Is Comparable To The Risk In Known High-Risk Groups Within The General Population: Report From The Late Effects Study Group (LESG)

The Effect of Fresh Frozen Plasma On the Incidence of Venous Thromboembolism and Haemorrhages in Children with Acute Lymphoblastic Leukaemia

Transplantation of Human Umbilical Cord Blood Cells in Macrophage-Depleted SCID Mice: Evidence for Accessory Cell Involvement in Expansion of Immature CD34 + CD38 − Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only